Your browser doesn't support javascript.
loading
Blockade of tumor necrosis factor superfamily members CD30 and OX40 abrogates disease activity in murine immune-mediated glomerulonephritis.
Artinger, Katharina; Kirsch, Alexander H; Mooslechner, Agnes A; Cooper, Daniel J; Aringer, Ida; Schuller, Max; Schabhüttl, Corinna; Klötzer, Konstantin A; Schweighofer, Kerstin; Eller, Philipp; Yagita, Hideo; Illert, Anna L; Rosenkranz, Alexander R; Lane, Peter J; Eller, Kathrin.
Afiliação
  • Artinger K; Clinical Division of Nephrology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Kirsch AH; Clinical Division of Nephrology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Mooslechner AA; Clinical Division of Nephrology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Cooper DJ; Medical Research Council Centre for Immune Regulation, Institute for Biomedical Research, University of Birmingham, Birmingham, UK; Division of Global and Tropical Health, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia.
  • Aringer I; Clinical Division of Nephrology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Schuller M; Clinical Division of Nephrology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Schabhüttl C; Clinical Division of Nephrology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Klötzer KA; Clinical Division of Nephrology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Schweighofer K; Clinical Division of Nephrology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Eller P; Intensive Care Unit, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Yagita H; Department of Immunology, School of Medicine, Juntendo University, Tokyo, Japan.
  • Illert AL; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Rosenkranz AR; Clinical Division of Nephrology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Lane PJ; Medical Research Council Centre for Immune Regulation, Institute for Biomedical Research, University of Birmingham, Birmingham, UK.
  • Eller K; Clinical Division of Nephrology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. Electronic address: kathrin.eller@medunigraz.at.
Kidney Int ; 100(2): 336-348, 2021 08.
Article em En | MEDLINE | ID: mdl-33785369
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Receptores OX40 / Glomerulonefrite Limite: Animals Idioma: En Revista: Kidney Int Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Áustria
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Receptores OX40 / Glomerulonefrite Limite: Animals Idioma: En Revista: Kidney Int Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Áustria